{"id":533644,"date":"2021-09-02T07:03:51","date_gmt":"2021-09-02T11:03:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/"},"modified":"2021-09-02T07:03:51","modified_gmt":"2021-09-02T11:03:51","slug":"instil-bio-to-present-at-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/","title":{"rendered":"Instil Bio to Present at Upcoming Investor Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">DALLAS, Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Instil Bio, Inc. (\u201cInstil\u201d) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company management will participate in two upcoming investor conferences in September:<\/p>\n<p>\n        <strong>Morgan Stanley 19<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Fireside Chat: Thursday, September 9 at 2:00 p.m. ET<\/p>\n<p>\n        <strong>Baird\u2019s 2021 Virtual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Company Presentation: Tuesday, September 14 at 5:30 p.m. ET<\/p>\n<p>A live webcast, if recorded, of each presentation can be accessed under \u201cNews &amp; Events\u201d in the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YPaA5E3xrbXZPheD8YX7PX2HLNxjuIeWGzhhYFA3LgsqiCh4lpEz8TDQPgvHo8213EbpPc2p-LcwvSskk9TP5g==\" rel=\"nofollow noopener\" target=\"_blank\">www.instilbio.com<\/a>. The archived webcast will be available on the Company\u2019s website shortly after the event.<\/p>\n<p>\n        <strong>About Instil Bio<\/strong>\n      <\/p>\n<p>Instil Bio, Inc. (Nasdaq: TIL) is a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. The Company has assembled an accomplished management team with a successful track record in the development, manufacture, and commercialization of cell therapies. Using the Company\u2019s proprietary, optimized, and scalable manufacturing processes at its in-house manufacturing facilities, Instil is advancing its lead TIL product candidate, ITIL-168, for the treatment of advanced melanoma and other solid tumors as well as ITIL-306, a next-generation, genetically engineered TIL therapy for multiple solid tumors. For more information visit <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YPaA5E3xrbXZPheD8YX7PasVndyMw1eqzr1kjBg57REDwDYyoDRc2onmJDMezPhJ0G5pV9rdB3vB-eMcwnvl4w==\" rel=\"nofollow noopener\" target=\"_blank\">www.instilbio.com<\/a><\/u>\u00a0and LinkedIn.<\/p>\n<p align=\"left\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>Brendan Payne<\/strong><br \/>\n        <br \/>\n        <strong>Stern Investor Relations<\/strong><br \/>\n        <br \/>\n        <strong>1-212-362-1200<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I9El9Zc3IF1A0_j05-_T33XLMJnYbZFOpMz_nb_DBz6Fj6B52dPeH5kVnpZBFp75Na-wRA8aA29RILPUUGr89LZ60Liteuy_6748GBA8uaY=\" rel=\"nofollow noopener\" target=\"_blank\">brendan.payne@sternir.com<\/a>\u00a0\u00a0\u00a0\u00a0<\/p>\n<p align=\"left\">\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>\n        <strong>1-833-446-7845 Ext. 1009<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xxn2_aHtzo5vCrHFr5vnTpkPWhxRuNnkg-1mKP1IWbYILbNWaNGPnzq3GfRcr1GoMwE74n9jCqTuvinTJgK2xoJOaYCdTQVTcgWyisRsjQzjzXdFY1Nz1jnjYpJk5Xq0\" rel=\"nofollow noopener\" target=\"_blank\">mediarelations@instilbio.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWE0YzIyMzUtMDdkYi00Y2FmLTkxMzktZWJjMWQxYTc5OTUwLTEyMTg5MDE=\/tiny\/Instil-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DALLAS, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Instil Bio, Inc. (\u201cInstil\u201d) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company management will participate in two upcoming investor conferences in September: Morgan Stanley 19 th Annual Global Healthcare Conference Fireside Chat: Thursday, September 9 at 2:00 p.m. ET Baird\u2019s 2021 Virtual Global Healthcare Conference Company Presentation: Tuesday, September 14 at 5:30 p.m. ET A live webcast, if recorded, of each presentation can be accessed under \u201cNews &amp; Events\u201d in the Investors section of the Company\u2019s website at www.instilbio.com. The archived webcast will be available on the Company\u2019s website shortly after the event. About Instil &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Instil Bio to Present at Upcoming Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533644","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DALLAS, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Instil Bio, Inc. (\u201cInstil\u201d) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company management will participate in two upcoming investor conferences in September: Morgan Stanley 19 th Annual Global Healthcare Conference Fireside Chat: Thursday, September 9 at 2:00 p.m. ET Baird\u2019s 2021 Virtual Global Healthcare Conference Company Presentation: Tuesday, September 14 at 5:30 p.m. ET A live webcast, if recorded, of each presentation can be accessed under \u201cNews &amp; Events\u201d in the Investors section of the Company\u2019s website at www.instilbio.com. The archived webcast will be available on the Company\u2019s website shortly after the event. About Instil &hellip; Continue reading &quot;Instil Bio to Present at Upcoming Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Instil Bio to Present at Upcoming Investor Conferences in September\",\"datePublished\":\"2021-09-02T11:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":257,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/\",\"name\":\"Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\",\"datePublished\":\"2021-09-02T11:03:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Instil Bio to Present at Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk","og_description":"DALLAS, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Instil Bio, Inc. (\u201cInstil\u201d) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that company management will participate in two upcoming investor conferences in September: Morgan Stanley 19 th Annual Global Healthcare Conference Fireside Chat: Thursday, September 9 at 2:00 p.m. ET Baird\u2019s 2021 Virtual Global Healthcare Conference Company Presentation: Tuesday, September 14 at 5:30 p.m. ET A live webcast, if recorded, of each presentation can be accessed under \u201cNews &amp; Events\u201d in the Investors section of the Company\u2019s website at www.instilbio.com. The archived webcast will be available on the Company\u2019s website shortly after the event. About Instil &hellip; Continue reading \"Instil Bio to Present at Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:03:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Instil Bio to Present at Upcoming Investor Conferences in September","datePublished":"2021-09-02T11:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/"},"wordCount":257,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/","name":"Instil Bio to Present at Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=","datePublished":"2021-09-02T11:03:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTExMyM0Mzg1OTU4IzIyMDczNDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/instil-bio-to-present-at-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Instil Bio to Present at Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533644"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533644\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}